• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Lebwohl MG, Leonardi C, Menter A, et al. Tildrakizumab efficacy by metabolic syndrome status in psoriasis: post hoc analysis of 3-year data from the phase 3 reSURFACE 1 study. Poster presented at: 28th European Academy of Dermatology

home / authors / lebwohl-mg-leonardi-c-menter-a-et-al-tildrakizumab-efficacy-by-metabolic-syndrome-status-in-psoriasis-post-hoc-analysis-of-3-year-data-from-the-phase-3-resurface-1-study-poster-presented-at-28th-european-academy-of-dermatology

Articles

© 2024 MJH Life Sciences
AJMC®
All rights reserved.